These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15982359)

  • 1. The NF-kappaB pathway and the successful application of anti-inflammatory and angiostatic therapy in Langerhans' cell histiocytosis.
    Brown RE
    Br J Haematol; 2005 Jul; 130(1):147-8. PubMed ID: 15982359
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults.
    Reichle A; Vogt T; Kunz-Schughart L; Bretschneider T; Bachthaler M; Bross K; Freund S; Andreesen R
    Br J Haematol; 2005 Mar; 128(5):730-2. PubMed ID: 15725096
    [No Abstract]   [Full Text] [Related]  

  • 3. More on pamidronate in Langerhans'-cell histiocytosis.
    Brown RE
    N Engl J Med; 2001 Nov; 345(20):1503. PubMed ID: 11794213
    [No Abstract]   [Full Text] [Related]  

  • 4. Peperomins as anti-inflammatory agents that inhibit the NF-kappaB signaling pathway.
    Tsutsui C; Yamada Y; Ando M; Toyama D; Wu JL; Wang L; Taketani S; Kataoka T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4084-7. PubMed ID: 19559609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
    Haddad JJ
    Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo.
    Desai A; Konda VR; Darland G; Austin M; Prabhu KS; Bland JS; Carroll BJ; Tripp ML
    Inflamm Res; 2009 May; 58(5):229-34. PubMed ID: 19169645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors.
    D'Acquisto F; Ianaro A
    Curr Opin Pharmacol; 2006 Aug; 6(4):387-92. PubMed ID: 16781194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
    Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E
    Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis.
    Amir G; Weintraub M
    Pediatr Blood Cancer; 2008 Feb; 50(2):304-7. PubMed ID: 17455317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More on pamidronate in Langerhans'-cell histiocytosis.
    Egeler RM
    N Engl J Med; 2001 Nov; 345(20):1502-3. PubMed ID: 11794212
    [No Abstract]   [Full Text] [Related]  

  • 11. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
    Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of NF-kappaB signaling: 785 and counting.
    Gilmore TD; Herscovitch M
    Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.
    Song XM; Li JG; Wang YL; Hu ZF; Zhou Q; Du ZH; Jia BH
    Shock; 2008 Oct; 30(4):468-72. PubMed ID: 18391858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital Langerhans cell histiocytosis with isolated skin involvement.
    Schroth M; Hertzberg H; Langer T; Beck JD
    Med Pediatr Oncol; 2001 Jul; 37(1):73-4. PubMed ID: 11466731
    [No Abstract]   [Full Text] [Related]  

  • 15. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
    Wong ET; Tergaonkar V
    Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
    Van Waes C
    Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-methyl-1,2-cyclopentanedione down-regulates age-related NF-kappaB signaling cascade.
    Chung JH; Choi SY; Kim JY; Kim DH; Lee JW; Choi JS; Chung HY
    J Agric Food Chem; 2007 Aug; 55(16):6787-92. PubMed ID: 17629301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling.
    Redlak MJ; Power JJ; Miller TA
    J Surg Res; 2008 Mar; 145(1):66-73. PubMed ID: 17644113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
    Xiao G; Rabson AB; Young W; Qing G; Qu Z
    Cytokine Growth Factor Rev; 2006 Aug; 17(4):281-93. PubMed ID: 16793322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
    Dejardin E
    Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.